BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11481915)

  • 1. [PROGRESS Study examines transient cerebral ischemia and stroke patients. Future goal: attaining basic blood pressure control].
    Einecke D
    MMW Fortschr Med; 2001 Jul; 143(26-27):4-5. PubMed ID: 11481915
    [No Abstract]   [Full Text] [Related]  

  • 2. [PROGRESS--a trial on blood pressure lowering after stroke and TIA. ACE inhibitors and diuretics reduce the risk of new stroke].
    Terént A
    Lakartidningen; 2002 May; 99(20):2286-8, 2291. PubMed ID: 12082946
    [No Abstract]   [Full Text] [Related]  

  • 3. [Management of hypertension in elderly patients with stroke].
    Bokura H; Kobayashi S
    Nihon Rinsho; 2005 Jun; 63(6):1029-32. PubMed ID: 15948386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
    J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
    Chalmers J; Neal B; MacMahon S;
    J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Newly diagnosed hypertensive. It calls for treatment immediately with a combination ].
    MMW Fortschr Med; 2003 Nov; 145(45):48. PubMed ID: 14712787
    [No Abstract]   [Full Text] [Related]  

  • 8. Fixed combination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after acute administration.
    Joannides R; Bellien J; Thurlure C; Iacob M; Abeel M; Thuillez C
    Am J Hypertens; 2008 Jun; 21(6):679-84. PubMed ID: 18443573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
    Bath P
    Stroke; 2003 May; 34(5):1334-5. PubMed ID: 12702833
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of diuretics in combination with perindopril in hypertensive stroke patients: Results of the Japan Perindopril and Diuretics on Cerebrovascular Disease Study (J-PADOC).
    Hasegawa Y; Shimada K; Yamaguchi T
    Blood Press Suppl; 2010 Feb; 1():10-6. PubMed ID: 20175714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke].
    Masson C
    Presse Med; 2001 Nov; 30(35):1716-7. PubMed ID: 11775593
    [No Abstract]   [Full Text] [Related]  

  • 12. Perindopril + indapamide: new preparation. Simple trick.
    Prescrire Int; 1999 Dec; 8(44):172-5. PubMed ID: 11503814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ; Ferrari R; Simoons ML
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy.
    Bugnicourt JM; Chillon JM; Canaple S; Lamy C; Godefroy O
    Fundam Clin Pharmacol; 2008 Apr; 22(2):217-22. PubMed ID: 18353116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed models showed no need for initial response monitoring after starting antihypertensive therapy.
    Bell KJ; Hayen A; Macaskill P; Craig JC; Neal BC; Irwig L
    J Clin Epidemiol; 2009 Jun; 62(6):650-9. PubMed ID: 19108988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antihypertensive therapy in diabetic patients. What do the new data mean for the practice?].
    Holzgreve H
    MMW Fortschr Med; 2007 Sep; 149(38):19. PubMed ID: 18018408
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
    Laurent S
    J Hypertens Suppl; 2001 Nov; 19(4):S9-14. PubMed ID: 11848262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs.
    Silvestre JS; Kamsu-Kom N; Clergue M; Duriez M; Lévy BI
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1038-43. PubMed ID: 12438525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.
    Dufouil C; Chalmers J; Coskun O; Besançon V; Bousser MG; Guillon P; MacMahon S; Mazoyer B; Neal B; Woodward M; Tzourio-Mazoyer N; Tzourio C;
    Circulation; 2005 Sep; 112(11):1644-50. PubMed ID: 16145004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.